Literature DB >> 22162471

Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome.

Eugenia Resmini1, Alicia Santos, Beatriz Gómez-Anson, Yolanda Vives, Patricia Pires, Iris Crespo, Maria J Portella, Manel de Juan-Delago, Maria-José Barahona, Susan M Webb.   

Abstract

CONTEXT: Cushing's syndrome (CS) affects cognition and memory.
OBJECTIVE: Our objective was to evaluate memory and hippocampal volumes (HV) on 3-tesla magnetic resonance imaging (3T MRI) in CS patients and controls. PATIENTS AND METHODS: Thirty-three CS patients (11 active, 22 cured) and 34 controls matched for age, sex, and education underwent Rey Auditory Verbal Learning Test and Rey-Osterrieth Complex Figure memory tests. Gray matter and HV were calculated on 3T MRI, using FreeSurfer image analyses software.
RESULTS: No differences in HV were observed between active and cured CS or controls. Memory performance was worse in CS patients than controls (P < 0.04 in active; P < 0.03 in cured CS) but did not differ among CS groups, which were therefore analyzed together; they performed worse for verbal (P = 0.02) and visual memory (P = 0.04) than controls. In 12 CS patients, memory was below normative cutoff values for verbal (n = 6, cured), visual memory (n = 10, six cured) or both (n = 4); these patients with severe memory impairments showed smaller HV compared with their matched controls (P = 0.02 with verbal impairment; P = 0.03 with visual impairment). They were older (P = 0.04), had shorter education (P = 0.02), and showed a trend toward longer duration of hypercortisolism (P = 0.07) than the remaining CS patients. Total (P = 0.004) and cortical (P = 0.03) brain gray matter volumes were decreased in CS compared with controls, indicating brain atrophy, whereas subcortical gray matter (which includes HV) was reduced only in the 12 patients with severe memory impairment.
CONCLUSION: Verbal and visual memory is worse in CS patients than controls, even after biochemical cure. HV was decreased only in those whose memory scores were below normative cutoff values.

Entities:  

Mesh:

Year:  2011        PMID: 22162471     DOI: 10.1210/jc.2011-2231

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  34 in total

Review 1.  Effects of cocaine on the hypothalamic-pituitary-adrenal axis.

Authors:  L Manetti; F Cavagnini; E Martino; A Ambrogio
Journal:  J Endocrinol Invest       Date:  2014-05-23       Impact factor: 4.256

2.  Computerized Analysis of Brain MRI Parameter Dynamics in Young Patients With Cushing Syndrome-A Case-Control Study.

Authors:  Amit Tirosh; Harish RaviPrakash; Georgios Z Papadakis; Christina Tatsi; Elena Belyavskaya; Lyssikatos Charalampos; Maya B Lodish; Ulas Bagci; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

3.  White matter involvement on DTI-MRI in Cushing's syndrome relates to mood disturbances and processing speed: a case-control study.

Authors:  Patricia Pires; Alicia Santos; Yolanda Vives-Gilabert; Susan M Webb; Aitor Sainz-Ruiz; Eugenia Resmini; Iris Crespo; Manel de Juan-Delago; Beatriz Gómez-Anson
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

4.  Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Authors:  Iris Crespo; Alicia Santos; Beatriz Gómez-Ansón; Olga López-Mourelo; Patricia Pires; Yolanda Vives-Gilabert; Susan M Webb; Eugenia Resmini
Journal:  Endocrine       Date:  2016-04-21       Impact factor: 3.633

5.  White matter alterations in the brains of patients with active, remitted, and cured cushing syndrome: a DTI study.

Authors:  P Pires; A Santos; Y Vives-Gilabert; S M Webb; A Sainz-Ruiz; E Resmini; I Crespo; M de Juan-Delago; B Gómez-Anson
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-30       Impact factor: 3.825

Review 6.  Clinical consequences of Cushing's syndrome.

Authors:  Elena Valassi; Iris Crespo; Alicia Santos; Susan M Webb
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

7.  Reduced DNA methylation of FKBP5 in Cushing's syndrome.

Authors:  Eugenia Resmini; Alicia Santos; Anna Aulinas; Susan M Webb; Yolanda Vives-Gilabert; Olivia Cox; Gary Wand; Richard S Lee
Journal:  Endocrine       Date:  2016-09-23       Impact factor: 3.633

8.  Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.

Authors:  Javier de Diego-Adeliño; Maria J Portella; Beatriz Gómez-Ansón; Olga López-Moruelo; Maria Serra-Blasco; Yolanda Vives; Dolors Puigdemont; Rosario Pérez-Egea; Enric Álvarez; Víctor Pérez
Journal:  J Psychiatry Neurosci       Date:  2013-03       Impact factor: 6.186

9.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

Review 10.  Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.

Authors:  Lu Gao; Lu Liu; Lin Shi; Yishan Luo; Zihao Wang; Xiaopeng Guo; Bing Xing
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.